WallStreetZenWallStreetZen

NASDAQ: AGRX
Agile Therapeutics Inc Stock Ownership - Who owns Agile Therapeutics?

Buy AGRX

Insider buying vs selling

Have Agile Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Perceptive Advisors LLC10% Owner2021-10-135,734,560$0.85
$4.87MBuy

1 of 1

AGRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

AGRX Shareholders

What type of owners hold Agile Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC55.49%21,654,485$11.65MInsider
Care Capital Iii LLC14.15%5,520,378$2.97MInsider
Jay Moorin12.98%5,065,086$2.73MInsider
Aisling Capital Iii LP12.19%4,755,628$2.56MInsider
Ab Investor8.99%3,509,949$1.89MInsider
Andrew N. Schiff5.57%2,171,831$1.17MInsider
Alfred Altomari1.47%573,734$308.67kInsider
Perceptive Advisors LLC1.36%532,361$286.41kInstitution
Dennis Reilly0.79%310,130$166.85kInsider
Renaissance Technologies LLC0.31%122,455$65.88kInstitution

1 of 3

AGRX vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AGRX2.44%97.56%Net Buying
CYTH0.52%99.48%Net BuyingNet Buying
RMTI5.89%94.11%
HAPP1.34%0.00%
SBFM3.90%0.82%Net SellingNet Buying

Agile Therapeutics Stock Ownership FAQ

Who owns Agile Therapeutics?

Agile Therapeutics (NASDAQ: AGRX) is owned by 2.82% institutional shareholders, 112.65% Agile Therapeutics insiders, and 0.00% retail investors. Perceptive Advisors LLC is the largest individual Agile Therapeutics shareholder, owning 21.65M shares representing 55.49% of the company. Perceptive Advisors LLC's Agile Therapeutics shares are currently valued at $11.33M.

If you're new to stock investing, here's how to buy Agile Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.